Stem Cell Manufacturing Market – Global Industry Analysis and Forecast (2023 to 2029)

Stem Cell Manufacturing Market was valued at US$ 12.87 Bn. in 2022. Global Stem Cell Manufacturing Market size is estimated to grow at a CAGR of 9.1 % over the forecast period.
Stem Cell Manufacturing Market Overview:
The report explores the Stem Cell Manufacturing market's segments (Product, Application, Technology, and Therapy). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). This market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2018 to 2022. The report investigates the Stem Cell Manufacturing market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Stem Cell Manufacturing market's contemporary competitive scenario. To know about the Research Methodology :- Request Free Sample Report
Stem Cell Manufacturing Market Dynamics:
Increasing venture capital investments in stem cell research with the prevalence of rare genetic diseases:

Stem cells are critical in illness management as well as specific research projects including customized medicine and genetic testing. As public and private stakeholders worldwide become more aware of stem cells' therapeutic potential and the scarcity of treatments for orphan illnesses, they are increasingly investing in the development of stem cell-based technology. The market for stem cell therapy is expected to develop as the prevalence of uncommon genetic illnesses rises. Rare disorders such as thalassemia, phenylketonuria, cystic fibrosis, and others affect millions of individuals each year.

Additionally, the growing geriatric population and rising incidences of cancer will act as a major factor in manipulating the growth of the stem cell manufacturing market. Along with this, rising urbanization and rising level of personal disposable income are the driving factors accelerating the growth of the stem cell manufacturing market. Also, growing expenditure on healthcare infrastructure is the main market driver that will further escalate the growth of the stem cell manufacturing market. Additionally, growing awareness about the therapeutic potency of stem cell products will cushion the market's growth rate.

Growing market focus on mesenchymal stem cells and induced pluripotent stem cells:

Also, the rising focus of leading market players on mesenchymal stem cells and encouraged pluripotent stem cells will provide beneficial opportunities for the stem cell manufacturing market growth. Along with this, a supportive regulatory framework across developing countries will propel the market's growth rate in the coming years. Also, the growing adoption of advanced technologies and increasing the number of emergent markets will extra provide beneficial opportunities for the stem cell manufacturing market growth during the forecast period.

The higher operational cost associated with stem cell manufacturing and banking:

Manufacturing scale-up of stem cell lines and related accessories is frequently accompanied by major technological challenges that obstruct the whole manufacturing process and result in large operational expenditures. As a result, stem cell products are frequently more expensive than pharmaceutical medications and biologics. On the other hand, technical limitations linked with manufacturing scale-up will task the stem cell manufacturing market. Additionally, the lack of skilled professionals and socio-ethical concerns related to the use of allogenic and human embryonic stem cells will restrain and further hinder the growth rate of the market during the forecast period of 2023-2029.

Stem Cell Manufacturing Market Trends:

Growing awareness among the masses about the potential of stem cell products in medical applications is primarily producing the global stem cell manufacturing market to pick up at an extensive pace. Instantaneously, extensive advancements are occurring in the field of stem cell research, and revolutionary techniques are being discovered almost every year. This has attracted a substantial number of people to work in this sector, consequently pushing the stem cell manufacturing market to increase boundless growth. However, the high costs of research and manufacturing processes are restraining the market.

Some regions depict the presence of stringent regulations when it comes to stem cell manufacturing, thus hindering the market expansion. But many businesses are focusing on developing cost-effective stem cell manufacturing processes, which is expected to reduce the impact of restraints in the upcoming years. The stem cell manufacturing market is expected to gain market growth in the forecast period. The growth in awareness of diseases such as cancer, hematopoietic disorders, and degenerative disorders is going to drive the growth of the market.

Stem cells play a vital role in the development and preparation of drugs that have been found suitable in the treatment of various diseases for which medical science had not even discovered like the ongoing pandemic. The key driver behind the rise of the stem cell manufacturing market has been that stem cells play an important role in disease management and research initiatives. The growing awareness about the use of stem cells in the therapeutic f various organ diseases has driven private players to invest more in the market and gain better results.

The increased number of stem cell organizations has also boosted the market growth and the sudden increase in the use of stem cells in oncology for the treatment of cancer and tumors has generated a positive impact in the minds of the public at large towards the increased use of stem cell manufacturing process which has boosted the growth for stem cell manufacturing market. An increase in the R&D activities in the pharmaceutical and biotechnology sector, stem cell therapy including cell therapy and gene therapy along with animal biotechnology sector, for the production of better yield is likely to accelerate the growth of the stem cell manufacturing market during the forecast period.
Stem Cell Manufacturing Market Segment Analysis:
By application, the Stem Cell Manufacturing Market is segmented into Regenerative Medicine and Drug Discovery and development. The Regenerative Medicine segment dominated the largest market share accounting for XX% in 2022 and is expected to grow at a CAGR of 3% during the forecast period. This is because of the increasing approval for stem cell therapy and clinical trials targeting different diseases. For example, in June 2020, Longeveron LLC announced Japan’s Pharmaceutical and Medical Devices Agency (PMDA) approval for the starting Phase 2 clinical trial for evaluating the safety and efficacy of their Mesenchyme Stem Cells (LMSCs) that can be used for treating aging frailty.

Besides, several governments are investing heavily in the development of regenerative medicines. For instance, in March 2020, the Government of Canada invested around USD 6.9 million in regenerative medicine research. The funds will support 4 clinical trials and 9 translational projects aimed to bring new therapies into the regenerative medicine sector. The regenerative medicines developed will help in the treatment of various heart diseases, blood disorders, vision loss, and diabetes.

By product, the Stem Cell Manufacturing Market is segmented into Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), and Induced Pluripotent Sand and Cells (iPSCs), and Very Small Embryonic Like Stem Cells. The Adult Stem Cell segment dominated the largest market share accounting for xx% in 2022 and is expected to grow at a CAGR of 3% during the forecast period. The factors that contributed to the growth of the segment include the presence of minimal controversial issues concerning ethics, immune rejection, and tumor genesis. The application of ASCs in regenerative medicines can be further attributed to the segment growth. The ASCs bioprocessing for regenerative medicine is anticipated to face challenges during process development.ASCs are further segmented into hematopoietic stem cells, mesenchymal stem cells (MSCs), neural stem cells, and epithelial/skin stem cells. The MSC segment is anticipated to expand at the fastest CAGR during the forecast period owing to its potential use in autologous transplantation, large clinical trials conducted that marked its application in the treatment of various diseases, and extensive research exploring its therapeutic applications.
Stem Cell Manufacturing Market Regional Insights:
The North American region emerged as the dominant regional market share accounting for 3.4% in 2022. This is because of several factors such as the presence of key players engaged in developing stem cell therapies, advanced healthcare infrastructure, extensive R&D, supportive reforms from healthcare organizations, and, strong reimbursement policies. The U.S. is the leading country in the region owing to government initiatives and high research activities in the country.

The Asia Pacific region is expected to be the second dominant region in this market. This is because of the increasing development of stem cell-based therapies, government initiatives for developing regenerative medicines, the setup of several stem cell banks, and increasing clinical trials for regenerative medicines in the region. For instance, in July 2020, MEDIPOST announced the results of NEUROSTEM’s phase 1/2a study. It is an investigational stem cell therapy that can be used for treating Alzheimer’s disease.

The objective of the report is to present a comprehensive analysis of the global Stem Cell Manufacturing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear, futuristic view of the industry to the decision-makers.

The reports also help in understanding the Stem Cell Manufacturing Market dynamic and structure by analyzing the market segments and projecting the Stem Market size. Clear representation of competitive analysis of key players by Design, price, financial position, product portfolio, growth strategies, and regional presence in the Stem Cell Manufacturing Market make the report investor’s guide.
Stem Cell Manufacturing Market Scope: Inquire before buying



Global Stem Cell Manufacturing Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US$ 12.87 Bn.


Forecast Period 2023 to 2029 CAGR:
9.1%
Market Size in 2029:
US$ 23.68 Bn.


 Segments Covered:
by Product
Adult Stem Cells (ASCs)
Human Embryonic Stem Cells (HESCs)
Induced Pluripotent Stem Cells (iPSCs)
Very Small Embryonic-Like Cells


by Application
Regenerative Medicine
Drug Discovery and Development


by Technology
Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture


by Therapy
Autologous
Allogenic



STEM CELL MANUFACTURING Market by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Stem Cell Manufacturing Market Key Players:
1. CELGENE CORPORATION
2. ReNeuron Group plc.
3. Virgin Health Bank
4. Biovault family
5. Precious Cells International Ltd
6. Mesoblast Ltd
7. Caladrius
8. Seneca Biopharmaceuticals, Inc.
9. Opexa Therapeutics, Inc.
10.Pluristem Therapeutics Inc
11.STEMCELL Technologies Inc.
12.ThermoGenesis Holdings, Inc
13.Astellas Pharma Inc.
14.Cellular Engineering Technologies
15.BioTime, Inc.

Frequently Asked Questions:

1] What segments are covered in the Stem Cell Manufacturing Market report?
Ans. The segments covered in the Market report are based on Product, Application, Technology, and Therapy.

2] Which region is expected to hold the highest share in the Market?
Ans. The North American region is expected to hold the highest share in the Market.

3] What is the market size of the Market by 2029?
Ans. The market size of the Market by 2029 is US$ 23.68 Bn.

4] What is the forecast period for the Market?
Ans. The Forecast period for the Market is 2023-2029.

5] What was the market size of the Market in 2022?
Ans. The market size of the Market in 2022 was US$ 12.87 Bn